Fund Holdings — Atle Fund Management AB

Total Portfolio Value:
$226.51M
Total Bought:
$41.17M
Total Sold:
$33.14M
Net Transaction:
+$8.03M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Eli Lilly and Company(LLY)37,06834,602-2,466$28.68M$28.58M12.62%-$106.6K
AbbVie Inc.(ABBV)90,72389,227-1,496$15.99M$18.69M8.25%+$2.71M
UnitedHealth Group Incorporated(UNH)35,20225,782-9,420$17.88M$13.50M5.96%-$4.37M
Boston Scientific Corporation(BSX)154,222132,273-21,949$13.83M$13.34M5.89%-$486.9K
Merck & Co., Inc.(MRK)105,727127,679+21,952$10.40M$11.46M5.06%+$1.06M
Thermo Fisher Scientific Inc.(TMO)24,89622,857-2,039$12.92M$11.37M5.02%-$1.54M
Vertex Pharmaceuticals Incorporated(VRTX)22,25722,808+551$7.60M$11.06M4.88%+$3.46M
Cor Us Equity32,55331,553-1,000$7.31M$8.77M3.87%+$1.46M
Gilead Sciences, Inc.(GILD)076,998+76,998$0$8.63M3.81%+$8.63M
Stryker Corporation(SYK)25,66022,998-2,662$9.30M$8.56M3.78%-$734.6K
Neurocrine Biosciences, Inc.(NBIX)67,76375,881+8,118$9.29M$8.39M3.71%-$895.2K
Amgen Inc.(AMGN)27,41426,577-837$7.11M$8.28M3.66%+$1.17M
Intuitive Surgical, Inc.(ISRG)015,345+15,345$0$7.60M3.36%+$7.60M
Alkermes plcSHS(ALKS)266,499214,778-51,721$7.67M$7.09M3.13%-$577.9K
BeOne Medicines AGADS(ONC)10,90025,141+14,241$2.00M$6.84M3.02%+$4.84M
BridgeBio Pharma, Inc.(BBIO)103,032151,348+48,316$2.81M$5.23M2.31%+$2.42M
Ew Us Equity68,29659,696-8,600$5.07M$4.33M1.91%-$743.5K
UFP Technologies, Inc.(UFPT)23,15921,259-1,900$3.17M$4.29M1.89%+$1.12M
Krystal Biotech, Inc.(KRYS)9,20223,491+14,289$1.47M$4.24M1.87%+$2.76M
Cardinal Health, Inc.(CAH)30,68027,688-2,992$3.62M$3.81M1.68%+$196.8K
Mirum Pharmaceuticals, Inc.(MIRM)116,69277,263-39,429$4.81M$3.48M1.54%-$1.32M
DexCom, Inc.(DXCM)60,05745,841-14,216$4.68M$3.13M1.38%-$1.55M
Harmony Biosciences Holdings, Inc.(HRMY)120,50191,301-29,200$4.10M$3.03M1.34%-$1.07M
Aclx Us
COMMON STOCK
42,07144,171+2,100$3.30M$2.90M1.28%-$398.6K
Slno Us Equity30,94037,098+6,158$984.8K$2.65M1.17%+$1.67M
Nams Uq Equity
ORDINARY SHARES
138,983107,783-31,200$3.56M$2.21M0.97%-$1.35M
Vrna UsADS034,690+34,690$0$2.20M0.97%+$2.20M
iRhythm Holdings, Inc.(IRTC)020,547+20,547$0$2.15M0.95%+$2.15M
Summit Therapeutics Inc.(SMMT)101,177105,077+3,900$1.31M$2.03M0.89%+$712.3K
Revolution Medicines, Inc.(RVMD)62,16154,961-7,200$2.68M$1.94M0.86%-$740.1K
Bcax Us Equity0119,833+119,833$0$1.56M0.69%+$1.56M
Mrus Uq62,52135,292-27,229$2.62M$1.49M0.66%-$1.13M
Janux Therapeutics, Inc.(JANX)39,57346,808+7,235$2.08M$1.26M0.56%-$813.8K
Mereo BioPharma Group plcADS(MREO)390,000390,0000$1.37M$877.5K0.39%-$495.3K
Autolus Therapeutics plcADS(AUTL)479,644479,6440$1.06M$743.4K0.33%-$316.6K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)98,30498,3040$1.19M$522.0K0.23%-$665.5K
Cabaletta Bio, Inc.(CABA)247,454182,354-65,100$554.3K$252.6K0.11%-$301.7K
Amicus Therapeutics Inc
COM
326,8400-326,840$3.08M$0—-$3.08M
Intra-Cellular Therapies Inc71,1380-71,138$5.94M$0—-$5.94M
Mersana Therapeutics Inc538,6210-538,621$764.8K$0—-$764.8K
Pharvaris N V
COM
34,3280-34,328$652.9K$0—-$652.9K
Page 1 of 1
Atle Fund Management AB — 13F Holdings — Q1 2025 | TickerTrail